Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
103 Cards in this Set
- Front
- Back
WHAT IS THE GENERIC ACTION OF DIURETICS?
|
ALTER KIDNEY FUNCTION TO INCREASE THE URINE VOLUME
|
|
THIS CLASS OF DRUGS ALTERS KIDNEY FUNCTION TO INCREASE THE URINE VOLUME
|
DIURETICS
|
|
WHAT ARE THE FOUR GENERAL METHODS OF ACTION FOR DIURETICS?
|
ION TRANSPORT INHIBITORS, OSMOTIC AGENTS THAT PREVENT WATER REABSORPTION, ENZYME INHIBITORS, AND HORMONE INHIBITION
|
|
WHAT DO ION TRANSPORT INHIBITORS DO?
|
DECREASE THE REABSORPTION OF SODIUM
|
|
WHAT SUBTYPES OF DIURETICS ARE TRANSPORT INHIBITORS?
|
LOOPS AND THIAZIDES
|
|
WHAT DO OSMOTIC AGENTS (DIURETICS) DO?
|
PREVENT WATER REABSORPTION
|
|
MANNITOL IS WHAT TYPE OF AGENT
|
OSMOTIC DIURETIC
|
|
GENERAL METHOD OF ACTION OF SPIRONOLACTONE
|
HORMONE INHIBITING DIURETIC (IT IS AN ALDOSTERONE ANTAGONIST)
|
|
WHERE DO LOOP DIURETICS WORK?
|
ASCENDING LOOP OF HENLE
|
|
WHERE DO OSMOTIC AGENTS WORK?
|
THROUGHOUT THE KIDNEY
|
|
WHERE DOES ACETAZOLAMIDE WORK?
|
PCT
|
|
WHAT IS THE ONLY DIURETIC AGENT THAT WORKS PREDOMINATELY IN THE PROXIMAL TUBULE?
|
CARBONIC ANHYDRASE INHIBITOR
|
|
HOW DOES A CARBONIC ANHYDRASE INHIBITOR WORK?
|
INHIBITS CARBONIC ANHYDRASE FROM CONVERTING CO2 AND WATER TO BICARBONATE. THUS SODIUM BICARBONATE REABSORPTION IS BLOCKED
|
|
WHAT IS THE CLINICAL USE FOR ANHYDRASE INHIBITOR?
|
TOO WEAK TO USE FOR CHF OR HTN; USE FOR GLAUCOMA, MOUNTAIN SICKNESS, URINARY ALKALIZATION
|
|
HOW DOES CARBONIC ANHYDRASE INHIBITOR WORK IN GLAUCOMA PATIENTS?
|
REDUCES AQUEOUS HUMOR OUTFLOW BY BLOCKING CA IN CILIARY BODY WHICH SECRETES HCO3 INTO AQUEOUS HUMOR
|
|
FORM OF CA INHIBITOR USED FOR GLAUCOMA (NAME DRUG)
|
DORZALAMIDE (TRUSOPT)- OPHTHALMIC CARBONIC ANHYDRASE INHIBITOR
|
|
WHAT IS THE USE OF DORZOLAMIDE OR TRUSOPT?
|
IT IS AN OPHTHALMIC CA INHIBITOR USED IN THE EYE TO TREAT GLAUCOMA BY REDUCING AQUEOUS HUMOR PRODUCTION
|
|
IF YOU USED CA INHIBITOR SYSTEMICALLY, WHAT WOULD BE THE SIDE EFFECT?
|
THE BODY WOULD BECOME OVERALL ACIDOTIC, BUT THE URINE WOULD BE ALKALOTIC
|
|
WHAT TYPE OF AGENT IS DIAMOX (ACETAZOLAMIDE)?
|
CA INHIBITING DIURETIC
|
|
HOW DO CA INHIBITORS TREAT MOUNTAIN SICKNESS?
|
DECREASE THE AMOUNT AND PH OF CSF WHERE CA IS RESPONSIBLE FOR SECRETING BICARBONATE
|
|
WHY WOULD YOU USE CARBONIC ANHYDRASE INHIBITOR FOR URINARY ALKALINIZATION?
|
BECAUSE IT INCREASES EXCRETION OF WEAK ACIDS/ DECREASES THE EXCRETION OF WEAK BASES
|
|
WHAT ARE THE THREE CLINICAL USES FOR CARBONIC ANHYDRASE INHIBITOR?
|
MOUNTAIN SICKNESS, GLAUCOMA, AND URINARY ALKALINIZATION
|
|
WHAT DIURETICS ACT MOSTLY IN THE DESCENDING LOOP OF HENLE?
|
NO DIURETICS HAVE MAJOR ACTION HERE
|
|
THE CELLS IN THE ASCENDING LOOP OF HENLE ARE ___________ TO WATER.
|
IMPERMEABLE
|
|
ACTIVE REABSORPTION OF THESE ELECTROLYTES OCCURS IN THE ASCENDING LOOP OF HENLE
|
SODIUM, POTASSIUM, CHLORIDE IONS
|
|
WHAT IS THE SITE OF ACTION FOR LOOP DIURETICS?
|
THE ASCENDING LOOP OF HENLE
|
|
HOW DO LOOP DIURETICS IN THE ASCENDING LOOP OF HENLE CAUSE DIURESIS?
|
LOOP DIURETICS BLOCK NACL AND POTASSIUM REABSORPTION RESULTING IN MORE SODIUM IN THE URINE AND THUS MORE WATER IN THE URINE; ALSO CAUSE THE LOSS OF CALCIUM AND MAGNESIUM
|
|
WHY ARE LOOP DIURETICS LESS BENEFICIAL TO LITTLE OLD LADIES WITH OSTEOPOROSIS THAN THIAZIDE DIURETICS?
|
BECAUSE LOOP DIURETICS CAUSE LOSS OF CALCIUM IN THE URINE WHEREAS THIAZIDE DIURETICS INCREASE THE AMOUNT OF CA THAT IS REABSORBED IN THE BODY
|
|
MOST COMMON LOOP DIURETICS
|
FUROSEMIDE (LASIX); BUMETANIDE (BUMEX); TORSEMIDE (DEMADEX)
|
|
THE THREE MOST COMMON LOOP DIURETICS ALL CONTAIN WHAT
|
SULFA
|
|
WHAT LOOP DIURETIC CAN BE PRESCRIBED TO SOMEONE WITH A SULFA ALLERGY?
|
ETHACRYNIC ACIC (EDECRIN)
|
|
WHAT IS THE MECHANISM OF ACTION OF LASIX (FUROSEMIDE)?
|
INHIBIT NA, K, AND CL REABSORPTION IN THE ASCENDING LOOP OF HENLE (INCREASES URINE OUTPUT)
|
|
LOOP DIURETICS ARRIVE AT THE SITE OF ACTION USING THE _________________ SYSTEM
|
ORGANIC ACID SECRETORY
|
|
CLINICAL USES FOR LOOP DIURETICS
|
PULMONARY EDEMA, CHF, HYPERTENSION, HYPERCALCEMIA
|
|
LOOP DIURETICS CAN BE USED IN PATIENTS WITH POOR RENAL FUNCTION. T OR F
|
TRUE
|
|
THIS TYPE OF DRUG CAN LEAD TO HYPOKALEMIA AND HYPOMAGNESEMIA
|
LOOP DIURETICS
|
|
WHY DO LOOP DIURETICS CAUSE HYPERURICEMIA?
|
THEY COMPETE WITH URIC ACID FROM THE ORGANIC ACID SECRETORY SYSTEM
|
|
ADVERSE EFFECTS OF LOOP DIURETICS INCLUDE
|
HYPOKALEMIA AND HYPOMAGNESEMIA, HYPERURICEMIA, OTOTOXICITY, HYPOVALEMIA LEADING TO HYPOTENSION, SKIN RASH AND PHOTOSENSITIVITY
|
|
WHAT TYPE OF SYMPTOMS MIGHT OCCUR IN A PERSON WITH SULFA ALLERGIES AFTER TAKING A LOOP DIURETIC?
|
SKIN RASH, ALLERGIC REACTION, AND PHOTOSENSITIVITY
|
|
WHAT IS THE SITE OF ACTION OF THIAZIDE DIURETICS?
|
THE DISTAL CONVOLUTED TUBULE
|
|
THE CELLS IN THE DCT ARE ______________ TO WATER
|
IMPERMEABLE
|
|
THIAZIDE DIURETICS CONTAIN SULFA SO PATIENTS WITH AN ALLERGY SHOULD BE GIVEN WHAT DRUG
|
THE LOOP DIURETIC ETHACRYNIC ACID
|
|
WHAT IS THE MECHANISM OF ACTION OF THIAZIDE DIURETICS?
|
REDUCE REABSORPTION OF SODIUM IN THE DISTAL TUBULE WHICH CAUSES LESS REABSORPTION OF WATER AND THUS INCREASED DIURESIS
|
|
HOW DO THIAZIDE DIURETICS ARRIVE AT THE KIDNEY?
|
BY THE ORGANIC SECRETORY SYSTEM (THAT IS WHY YOU USE CAUTION IN PATIENTS WITH GOUT BECAUSE THIS SYSTEM ALSO DELIVERS URIC ACID)
|
|
CLINICAL USES OF THIAZIDE DIURETICS
|
HYPERTENSION, CHF, HYPERCALCICURIA (KIDNEY STONES)
|
|
WHY WOULD YOU USE THIAIZIDE DIURETIC IN PEOPLE WITH HYPERCALCICURIA OR KIDNEY STONES?
|
IT INCREASES THE ABSORPTION OF CALCIUM FROM THE URINE BACK INTO THE BODY
|
|
ADVERSE EFFECTS OF THIAZIDE DIURETICS
|
POTASSIUM DEPLETION; HYPERURICEMIA, PHOTOSENSITIVITY, SMALL ADVERSE EFFECT ON LIPID PROFILE, HYPERGLYCEMIA
|
|
MOST COMMON THIAZIDE
|
HYDROCHLOROTHIAZIDE (HCTZ, ESIDRIX,ORETIC, HYDRODIURIL)
|
|
THIS NON THIAZIDE DIURETIC HAS LESS EFFECT IN THE LIPID PROFILE AND LESS LIKELY TO CAUSE HYPERGLYCEMIA
|
INDAPAMIDE (LOZOL)
|
|
ALTHOUGH THESE DRUGS DO CAUSE HYPERGLYCEMIA THEY ARE NOT CONTRAINDICATED IN DIABETES
|
THIAZIDE DIURETICS
|
|
WHY DO THIAZIDE DIURETICS CAUSE HYPERGLYCEMIA AS AN ADVERSE AFFECT?
|
THEY CAUSE LOW POTASSIUM SO THERE IS DIMINISHED ABILITY TO MOVE GLUCOSE INTO CELLS FROM THE BLOOD
|
|
WHAT IS THE INDICATION FOR METOLAZONE?
|
USE IN PATIENTS THAT NEED A THIAZIDE DIURETIC BUT THAT HAVE POOR RENAL FUNCTION (GFR BELOW 300)
|
|
WHAT HAPPENS WHEN ALDOSTERONE RECEPTORS IN THE COLLECTING TUBE AND DUCTS ARE STIMULATED?
|
CAUSES NA REABSORPTION AND K SECRETION
|
|
THIS IS THE SITE OF ACTION FOR THE POTASSIUM SPARING DIURETICS
|
COLLECTING TUBULE AND DUCT
|
|
WHAT IS ALDOSTERONISM?
|
HIGH LEVEL OF ALDOSTERONE SECRETION
|
|
THESE TWO DRUGS ARE ALDOSTERONE ANTAGONISTS?
|
SPIRONOLACTONE (ALDACTONE) AND EPLERENONE (INSPRA)
|
|
WHAT IS THE MOA FOR TRIAMTERENE (DYRENIUM) AND AMILORIDE (MIDAMOR)?
|
INHIBIT NA FLUX THRU THE ION CHANNEL IN THE LUMEN MEMBRANE (IN THE COLLECTING DUCT AND TUBULE); THUS INHIBIT NA REABSORPTION AND K SECRETION
|
|
WHAT IS THE CLINICAL USE OF POTASSIUM SPARING DIURETICS (AST)?
|
HYPERTENSION IN CONJUNCTION WITH HYPOKALEMIA, PRIMARY OR SECONDARY ALDOSTERONISM
|
|
ADVERSE REACTIONS OF K SPARING DIURETICS
|
HYPERKALEMIA
|
|
THIS SIDE EFFECT IS PARTICULAR TO SPIRONOLACTONE (A POTASSIUM SPARING DIURETIC)
|
GYNECOMASTIA AND MENSTRUAL IRREGULARITIES
|
|
WHAT TWO OVERLAPPING MECHANISMS CONTROL CARDIAC OUTPUT AND PERIPHERAL RESISTANCE?
|
SYMPATHETIC NERVOUS SYSTEM AND RAAS
|
|
WHEN BARORECEPTORS IN THE KIDNEY SENSE REDUCED ARTERIAL PRESSURE, WHAT DO THEY DO?
|
RELEASE THE ENZYME RENIN
|
|
WHAT IS THE FUNCTION OF ANGIOTENSIN II?
|
STIMULATES ALDOSTERONE SECRETION WHICH CAUSES RENAL SODIUM REABSORPTION
|
|
WHAT IS THE MOA OF SPIRONOLACTONE AND EPLERENONE IF THEY ARE ALDOSTERONE ANTAGONISTS?
|
ALDOSTERONE NORMALLY CAUSES NA AND WATER SAVING, SO IF ALDOSTERONE IS INHIBITED, K WILL BE SPARED AND NA AND H2O WILL GO OUT IN URINE
|
|
SPIRONOLACTONE IS THE K SPARING DIURETIC THAT IS APPROVED FOR WHAT CONDITION?
|
HEART FAILURE
|
|
WHY DOES SPIRINOLACTONE REDUCE THE RISK OF DEATH AND HOSPITALIZATION IN PATIENTS WITH SEVERE HEART FAILURE
|
NOT BECAUSE OF ITS DIURETIC EFFECT BUT BECAUSE IT BLOCKS ALDOSTERONE WHICH PROMOTES FIBROSIS
|
|
ALDOSTERONE ANTAGONISTS WOULD BE USED IN CONJUNCTION WITH WHAT DRUG IN HF?
|
ACE INHIBITORS
|
|
WHAT DOES ALDOSTERONE DO TO THE HEART AND BLOOD VESSELS?
|
STIFFENS THEM
|
|
WHEN A PATIENT IS TAKING AN ACE INHIBITOR WITH SPIRONOLACTONE, WHAT DO YOU MONITOR LEVELS OF?
|
POTASSIUM LEVELS
|
|
WHAT IS THE NAME OF THE OSMOTIC DIURETIC?
|
MANNITOL
|
|
WHAT TWO OVERLAPPING MECHANISMS CONTROL CARDIAC OUTPUT AND PERIPHERAL RESISTANCE?
|
SYMPATHETIC NERVOUS SYSTEM AND RAAS
|
|
WHEN BARORECEPTORS IN THE KIDNEY SENSE REDUCED ARTERIAL PRESSURE, WHAT DO THEY DO?
|
RELEASE THE ENZYME RENIN
|
|
WHAT IS THE FUNCTION OF ANGIOTENSIN II?
|
STIMULATES ALDOSTERONE SECRETION WHICH CAUSES RENAL SODIUM REABSORPTION
|
|
WHAT IS THE MOA OF SPIRONOLACTONE AND EPLERENONE IF THEY ARE ALDOSTERONE ANTAGONISTS?
|
ALDOSTERONE NORMALLY CAUSES NA AND WATER SAVING, SO IF ALDOSTERONE IS INHIBITED, K WILL BE SPARED AND NA AND H2O WILL GO OUT IN URINE
|
|
SPIRONOLACTONE IS THE K SPARING DIURETIC THAT IS APPROVED FOR WHAT CONDITION?
|
HEART FAILURE
|
|
WHY DOES SPIRINOLACTONE REDUCE THE RISK OF DEATH AND HOSPITALIZATION IN PATIENTS WITH SEVERE HEART FAILURE
|
NOT BECAUSE OF ITS DIURETIC EFFECT BUT BECAUSE IT BLOCKS ALDOSTERONE WHICH PROMOTES FIBROSIS
|
|
ALDOSTERONE ANTAGONISTS WOULD BE USED IN CONJUNCTION WITH WHAT DRUG IN HF?
|
ACE INHIBITORS
|
|
WHAT DOES ALDOSTERONE DO TO THE HEART AND BLOOD VESSELS?
|
STIFFENS THEM
|
|
WHEN A PATIENT IS TAKING AN ACE INHIBITOR WITH SPIRONOLACTONE, WHAT DO YOU MONITOR LEVELS OF?
|
POTASSIUM LEVELS
|
|
WHAT IS THE NAME OF THE OSMOTIC DIURETIC?
|
MANNITOL
|
|
WHY DO THIAZIDE DIURETICS CAUSE HYPERGLYCEMIA AS AN ADVERSE AFFECT?
|
THEY CAUSE LOW POTASSIUM SO THERE IS DIMINISHED ABILITY TO MOVE GLUCOSE INTO CELLS FROM THE BLOOD
|
|
WHAT IS THE INDICATION FOR METAZOLONE?
|
USE IN PATIENTS THAT NEED A THIAZIDE DIURETIC BUT THAT HAVE POOR RENAL FUNCTION (GFR BELOW 300)
|
|
WHAT HAPPENS WHEN ALDOSTERONE RECEPTORS IN THE COLLECTING TUBE AND DUCTS ARE STIMULATED?
|
CAUSES NA REABSORPTION AND K SECRETION
|
|
THIS IS THE SITE OF ACTION FOR THE POTASSIUM SPARING DIURETICS
|
COLLECTING TUBULE AND DUCT
|
|
WHAT IS ALDOSTERONISM?
|
HIGH LEVEL OF ALDOSTERONE SECRETION
|
|
THESE TWO DRUGS ARE ALDOSTERONE ANTAGONISTS?
|
SPIRONOLACTONE (ALDACTONE) AND EPLERENONE (INSPRA)
|
|
WHAT IS THE MOA FOR TRIAMTERENE (DYRENIUM) AND AMILORIDE (MIDAMOR)
|
INHIBIT NA FLUX THRU THE ION CHANNEL IN THE LUMEN MEMBRANE (IN THE COLLECTING DUCT AND TUBULE); THUS INHIBIT NA REABSORPTION AND K SECRETION
|
|
WHAT IS THE CLINICAL USE OF POTASSIUM SPARING DIURETICS (AST)?
|
HYPERTENSION IN CONJUNCTION WITH HYPOKALEMIA, PRIMARY OR SECONDARY ALDOSTERONISM
|
|
ADVERSE REACTIONS OF K SPARING DIURETICS
|
HYPERKALEMIA
|
|
THIS SIDE EFFECT IS PARTICULAR TO SPIRONOLACTONE (A POTASSIUM SPARING DIURETIC)
|
GYNECOMASTIA AND MENSTRUAL IRREGULARITIES
|
|
WHAT TWO OVERLAPPING MECHANISMS CONTROL CARDIAC OUTPUT AND PERIPHERAL RESISTANCE?
|
SYMPATHETIC NERVOUS SYSTEM AND RAAS
|
|
WHEN BARORECEPTORS IN THE KINDEY SENSE REDUCED ARTERIAL PRESSURE, WHAT DO THEY DO?
|
RELEASE THE ENZYME RENIN
|
|
WHAT IS THE FUNCTION OF ANGIOTENSIN II?
|
STIMULATES ALDOSTERONE SECRETION WHICH CAUSES RENAL SODIUM REABSORPTION
|
|
WHAT IS THE MOA OF SPIRONOLACTONE AND EPLERENONE (THEY ARE ALDOSTERONE ANTAGONISTS)?
|
ALDOSTERONE NORMALLY CAUSES NA AND WATER SAVING, SO IF ALDOSTERONE IS INHIBITED, K WILL BE SPARED AND NA AND H2O WILL GO OUT IN URINE
|
|
SPIRONOLACTONE IS THE K SPARING DIURETIC THAT IS APPROVED FOR WHAT CONDITION?
|
HEART FAILURE
|
|
WHY DOES SPIRINOLACTONE REDUCE THE RISK OF DEATH AND HOSPITALIZATION IN PATIENTS WITH SEVERE HEART FAILURE
|
NOT BECAUSE OF ITS DIURETIC EFFECT BUT BECAUSE IT BLOCKS ALDOSTERONE WHICH PROMOTES FIBROSIS
|
|
ALDOSTERONE ANTAGONISTS WOULD BE USED IN CONJUNCTION WITH WHAT DRUG IN HF?
|
ACE INHIBITORS
|
|
WHAT DOES ALDOSTERONE DO TO THE HEART AND BLOOD VESSELS?
|
STIFFENS THEM
|
|
WHEN A PATIENT IS TAKING AN ACE INHIBITOR WITH SPIRONOLACTONE, WHAT DO YOU MONITOR LEVELS OF?
|
POTASSIUM LEVELS
|
|
WHAT IS THE NAME OF THE OSMOTIC DIURETIC?
|
MANNITOL
|
|
HOW DOES MANNITOL WORK?
|
IT INCREASES THE OSMOTIC PRESSURE OF GLOMERULAR FILTRATE INHIBITING TUBULAR REABSORPTION OF H20 AND ELECTROLYTES, THEREBY INCREASING URINARY OUTPUT
|
|
WHAT IS THE CLINICAL USE OF MANNITOL?
|
PROMOTES URINARY EXCRETION OF TOXIC SUBSTANCES, DIURESIS IN ACUTE RENAL FAILURE, AND DECREASED INTRACRANIAL PRESSURE ASSOCIATED WITH CEREBRAL EDEMA
|
|
WHAT IS THE CONTRAINDICATION FOR MANNITOL?
|
AVOID USE IN ACTIVE INTRACRANIAL BLEEDS
|